Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

TORNTPHARM NSE

Key Fundamentals

LargecapPharmaceuticalsHealthcare
Market Cap
1.5L Cr
Volatility
Moderate
P/E Ratio
71.9
EBITDA
₹4,243 Cr
Return on Equity
24.16%
Debt to Equity
0.5
Book Value
₹247.88
EPS
₹49.44
52W High
₹4,712.9
52W Low
₹3,102

Technical Indicators

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%

Weaknesses

3
  • Stock is trading at 17.8 times its book value
  • The company has delivered a poor sales growth of 11.8% over past five years.
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
19.18% ↘
Net Income Growth
6.11% ↗
Cash Flow Change
-20.85% ↘
ROE
4.22% ↗
ROCE
1.42% ↗
EBITDA Margin (Avg.)
-4.28% ↘

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
2,491
2,591
2,660
2,732
2,745
2,859
2,889
2,809
2,959
3,178
3,302
3,303
4,197
Expenses
1,764
1,800
1,835
1,863
1,862
1,955
1,950
1,895
1,995
2,146
2,219
2,215
2,841
Operating Profit
727
791
825
869
883
904
939
914
964
1,032
1,083
1,088
1,356
OPM %
29%
31%
31%
32%
32%
32%
32%
33%
33%
32%
33%
33%
32%
Other Income
9
34
26
55
31
24
-16
33
-42
-37
-40
-23
-83
Interest
107
103
91
80
80
75
64
57
56
56
48
45
236
Depreciation
196
191
201
213
203
197
198
199
201
201
204
206
508
PBT
433
531
559
631
631
656
661
691
665
738
791
814
529
Tax %
34%
29%
31%
30%
29%
30%
31%
27%
25%
26%
25%
22%
31%
Net Profit
287
378
386
443
449
457
453
503
498
548
591
635
364
EPS in Rs
8.48
11.17
11.41
13.09
13.27
13.5
13.38
14.86
14.71
16.19
17.46
18.76
10.76
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
4,636
6,687
5,816
5,950
7,673
7,939
8,005
8,508
9,620
10,728
11,516
13,980
Expenses
3,616
3,954
4,438
4,601
5,690
5,769
5,524
6,077
6,778
7,360
7,795
9,421
Operating Profit
1,020
2,733
1,377
1,349
1,983
2,170
2,480
2,431
2,842
3,368
3,721
4,559
OPM %
22%
41%
24%
23%
26%
27%
31%
29%
30%
31%
32%
33%
Other Income
286
32
223
299
-300
121
57
-288
45
146
-1
-183
Interest
175
184
206
308
504
451
353
255
333
354
252
385
Depreciation
191
238
307
409
618
654
658
662
707
808
795
1,119
PBT
940
2,343
1,088
931
562
1,187
1,526
1,226
1,847
2,352
2,673
2,872
Tax %
20%
26%
14%
27%
22%
14%
18%
37%
33%
30%
28%
26%
Net Profit
751
1,733
934
678
436
1,025
1,252
777
1,245
1,656
1,911
2,138
EPS in Rs
22.19
51.22
27.59
20.04
12.89
30.28
36.99
22.97
36.79
48.94
56.47
63.17
Div. Payout %
25%
34%
25%
35%
66%
53%
47%
105%
60%
57%
57%
0%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
85
85
85
85
85
85
85
85
169
169
169
169
Reserves
2,406
3,409
4,266
4,538
4,640
4,739
5,753
5,868
6,029
6,687
7,421
8,220
Borrowings
2,740
2,352
2,510
6,462
6,038
5,784
4,874
4,070
5,369
4,022
3,202
15,025
Other Liabilities
2,589
3,040
2,740
3,159
3,351
3,402
3,363
2,884
3,043
3,627
3,603
20,898
Total Liabilities
7,820
8,886
9,601
14,243
14,113
14,010
14,075
12,906
14,610
14,505
14,396
44,312
Fixed Assets
2,833
2,859
3,688
7,855
7,748
7,533
7,065
6,423
8,121
8,138
7,947
33,376
CWIP
678
1,042
519
647
617
712
889
630
765
361
478
457
Investments
298
780
804
492
353
2
181
226
199
173
156
949
Other Assets
4,011
4,206
4,589
5,249
5,395
5,763
5,940
5,628
5,524
5,834
5,815
9,530
Total Assets
7,820
8,886
9,601
14,243
14,113
14,010
14,075
12,906
14,610
14,505
14,396
44,312
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
810
2,742
1,009
894
1,798
1,393
2,005
1,803
2,368
3,266
2,585
3,023
Investing
-2,113
-869
-798
-4,677
-246
229
-444
-196
-2,335
-160
-549
-12,713
Financing
1,212
-1,435
-193
3,417
-1,314
-1,549
-1,651
-1,781
77
-2,780
-2,298
10,151
Net Cash Flow
-90
437
18
-366
238
73
-89
-174
110
327
-262
461
Free Cash Flow
574
2,150
523
105
1,138
990
1,671
1,607
1,953
2,967
1,991
2,387
CFO/OP
85
121
101
87
105
77
88
91
97
112
86
84
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
125
79
60
77
68
76
69
70
74
63
59
79
Inventory Days
275
314
318
429
318
362
456
368
298
310
334
338
Days Payable
472
523
356
447
345
345
351
250
224
284
239
254
Cash Conversion Cycle
-71
-130
21
59
42
93
174
188
147
89
154
163
Working Capital Days
29
-1
28
-80
-62
-52
-5
7
-33
-27
7
-3
ROCE %
27%
48%
19%
13%
13%
15%
17%
19%
20%
23%
27%
15%

Shareholding Pattern

As of Mar 2026
Promoters 68.31%
FIIs 16.18%
DIIs 9.06%
Public 4.12%
Others 2.33%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Jul 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
71.25%
68.31%
68.31%
68.31%
68.31%
68.31%
68.31%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
14.14%
14.22%
14.46%
16.17%
16.31%
16.09%
15.92%
16.13%
16.18%
DIIs
6.53%
6.71%
6.76%
6.78%
7.52%
7.82%
7.76%
8.89%
8.87%
9.00%
8.31%
7.16%
6.44%
7.26%
7.27%
7.08%
8.35%
8.35%
8.65%
9.28%
9.14%
9.06%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
7.89%
7.72%
7.58%
7.29%
7.25%
7.10%
7.13%
4.59%
4.73%
4.47%
4.38%
4.25%
4.15%
4.09%
3.98%
4.34%
4.61%
4.51%
4.44%
4.08%
4.03%
4.12%
Others
14.33%
14.33%
14.42%
14.68%
13.98%
13.83%
13.86%
15.27%
15.16%
15.28%
16.07%
17.34%
18.16%
3.27%
3.28%
2.87%
2.56%
2.52%
2.50%
2.41%
2.38%
2.33%
No. of Shareholders
0
72,616
64,525
64,309
67,205
63,229
62,933
64,557
67,866
63,831
61,572
69,612
69,117
71,154
74,765
79,848
85,035
86,005
81,856
78,226
76,214
83,811

Documents

Frequently Asked Questions about Torrent Pharmaceuticals Ltd

What does Torrent Pharmaceuticals Ltd do?
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1] It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesse...
Where is Torrent Pharmaceuticals Ltd (TORNTPHARM) listed?
Torrent Pharmaceuticals Ltd is listed on the Indian stock exchanges. It is listed on NSE: TORNTPHARM and BSE: 500420. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Torrent Pharmaceuticals Ltd belong to?
Torrent Pharmaceuticals Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Torrent Pharmaceuticals Ltd?
Torrent Pharmaceuticals Ltd has a market capitalisation of approximately ₹153187.18 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Torrent Pharmaceuticals Ltd?
The Price-to-Earnings (PE) ratio of Torrent Pharmaceuticals Ltd is 71.90. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Torrent Pharmaceuticals Ltd?
Over the past 52 weeks, Torrent Pharmaceuticals Ltd has traded between a low of ₹3,102 and a high of ₹4,712.9. This range helps investors understand the stock's price volatility and recent trading levels.
Does Torrent Pharmaceuticals Ltd pay dividends?
Yes, Torrent Pharmaceuticals Ltd has a dividend yield of 0.84%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Torrent Pharmaceuticals Ltd?
Torrent Pharmaceuticals Ltd has a Return on Equity (ROE) of 24.16%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Torrent Pharmaceuticals Ltd on Tapetide?
On Tapetide, you can view Torrent Pharmaceuticals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1] It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Website torrentpharma.com
CEO Mr. Aman Mehta
Employees 17,059
Listed 2002-11-25
Face Value ₹ 5
Issued Size 33,84,45,440